SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-010271
Filing Date
2022-04-29
Accepted
2022-04-29 16:32:50
Documents
9
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pbyi20211123_def14a.htm DEF 14A 1018248
2 auerback01.jpg GRAPHIC 8362
3 boardtenure.jpg GRAPHIC 81362
4 notice1.jpg GRAPHIC 197008
5 notice2.jpg GRAPHIC 161245
6 pblogo01.jpg GRAPHIC 11354
7 pc1.jpg GRAPHIC 125052
8 pc2.jpg GRAPHIC 99008
9 picture1.jpg GRAPHIC 316521
  Complete submission text file 0001437749-22-010271.txt   2396467
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 22876232
SIC: 2834 Pharmaceutical Preparations